Evidence map›Paper›PMID 34031134›Full record

ArticleBMJ global health2021

Economic and cost-effectiveness analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials in India, Pakistan and Mozambique.

Jeffrey N Bone, Asif R Khowaja, Marianne Vidler, Beth A Payne, Mrutyunjaya B Bellad, Shivaprasad S Goudar, Ashalata A Mallapur, Khatia Munguambe, Rahat N Qureshi, Charfudin Sacoor and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01911494 (The CLIP), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01911494 nacompletednot on this map

The CLIP (Community Level Interventions for Pre-eclampsia) Cluster Randomized Controlled Trial

TypeinterventionalSponsorUniversity of British ColumbiaRan2013 to 2018Enrolled87,500ConditionsPre-eclampsia, Hypertension, Pregnancy InducedArmsCommunity Engagement, PIERS on the Move mHealth decision aid, Magnesium Sulfate, Methyldopa
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jeffrey N BoneDepartment of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-7704-1677
Asif R KhowajaSchool of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
Marianne VidlerDepartment of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-7633-8812
Beth A PayneSchool of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
Mrutyunjaya B BelladWomen's and Children's Health Research Unit, KLE Academy of Higher Education and Research, Belgaum, Karnataka, India.
Shivaprasad S GoudarWomen's and Children's Health Research Unit, KLE Academy of Higher Education and Research, Belgaum, Karnataka, India.
Ashalata A MallapurS Nijalingappa Medical College and HSK Hospital and Research Centre, Bagalkot, Karnataka, India.
Khatia MunguambeCentro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique.
Rahat N QureshiCentre of Excellence, Division of Woman and Child Health, Aga Khan University, Karachi, Pakistan.
Charfudin SacoorCentro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique.
Esperanca SeveneCentro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique.
Geert W J FrederixJulius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Zulfiqar A BhuttaCentre of Excellence, Division of Woman and Child Health, Aga Khan University, Karachi, Pakistan.
Craig MittonSchool of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
Laura A MageeDepartment of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada.
Peter von DadelszenDepartment of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada PVD@kcl.ac.uk.
CLIP Trials Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Community-Level Interventions for Pre-eclampsia (CLIP) trials (NCT01911494) in India, Pakistan and Mozambique (February 2014-2017) involved community engagement and task sharing with community health workers for triage and initial treatment of pregnancy hypertension. Maternal and perinatal mortality was less frequent among women who received ≥8 CLIP contacts. The aim of this analysis was to assess the incremental costs and cost-effectiveness of the CLIP intervention overall in comparison to standard of care, and by PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move (POM) mobile health application visit frequency.

methodsIncluded were all women enrolled in the three CLIP trials who had delivered with known outcomes by trial end. According to the number of POM-guided home contacts received (0, 1-3, 4-7, ≥8), costs were collected from annual budgets and spending receipts, with inclusion of family opportunity costs in Pakistan. A decision tree model was built to determine the cost-effectiveness of the intervention (vs usual care), based on the primary clinical endpoint of years of life lost (YLL) for mothers and infants. A probabilistic sensitivity analysis was used to assess uncertainty in the cost and clinical outcomes.

resultsThe incremental per pregnancy cost of the intervention was US$12.66 (India), US$11.51 (Pakistan) and US$13.26 (Mozambique). As implemented, the intervention was not cost-effective due largely to minimal differences in YLL between arms. However, among women who received ≥8 CLIP contacts (four in Pakistan), the probability of health system and family (Pakistan) cost-effectiveness was ≥80% (all countries).

conclusionThe intervention was likely to be cost-effective for women receiving ≥8 contacts in Mozambique and India, and ≥4 in Pakistan, supporting WHO guidance on antenatal contact frequency. TRIAL REGISTRATION NUMBER: NCT01911494.

Indexed as

Pre-EclampsiaCost-Benefit AnalysisFemaleHumansIndiaInfantMozambiquePakistanPregnancyhealth economicshypertensionintervention studymaternal healthobstetrics

Identifiers

PMID34031134
PMCPMC8149358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.